Impact of thymosin α1 as an immunomodulatory therapy on long-term survival of non-small cell lung cancer patients after R0 resection: a propensity score-matched analysis

por Guo, Cheng-Lin, Mei, Jian-Dong, Jia, Yu-Long, Gan, Fan-Yi, Tang, Yu-Dong, Liu, Cheng-Wu, Zeng, Zhen, Yang, Zhen-Yu, Deng, Sen-Yi, Sun, Xing, Liu, Lun-Xu
Publicado 2021